Highlights
NASDAQ: ALRN       Aileron Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
0.43   +0.013 (3.12%)  0.42 - 0.451  100,586

Overview

 
Avg Volume (4 weeks):433,048
4 Weeks Range:0.40 - 0.69
4 Weeks Price Volatility (%):
10.34%
52 Weeks Range:0.40 - 2.60
52 Weeks Price Volatility (%):
1.36%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing and commercializing a novel class of therapeutics called stapled peptides. Its lead product candidate, ALRN-6924, targets the tumor suppressor p53 for the treatment of a wide variety of cancers. ALRN-6924, reactivates p53-mediated tumor suppression by targeting the two primary p53 suppressor proteins, MDMX and MDM2.

  Be the first to like this.
 


 

1666  3801  600  2910 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 AABA 19.630.00 
 ACB 2.978+0.338 
 AMD 39.87-1.11 
 UBER 29.446+1.416 
 M 14.60-0.42 
 CHK 0.582+0.012 
 HEPA 3.76+1.34 
 SCHW 48.356+3.606 
 AMTD 49.19+7.81 
Partners & Brokers